Other Ticker:  
    Sector     Industry
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00

 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 458
 Employees -
 Revenues (TTM) (Millions $) 10,706
 Net Income (TTM) (Millions $) 1,775
 Cash Flow (TTM) (Millions $) 237
 Capital Exp. (TTM) (Millions $) 352

We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presence in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in collaboration with medical professionals, which enhance the quality of life for patients and improve outcomes for our customers and our shareholders.

We operate our business through five segments:

• Medical Devices, which includes the development, manufacture and sale of endomechanical instruments, soft tissue repair products, energy devices, oximetry and monitoring products, airway and ventilation products, vascular devices, sharpsafety products, clinical care products and other medical device products;

• Pharmaceutical Products, which includes the development, manufacture and distribution of dosage pharmaceuticals, active pharmaceutical ingredients and specialty chemicals;

• Imaging Solutions, which includes the development, manufacture and marketing of radiopharmaceuticals and contrast products;

• Medical Supplies, which includes the development, manufacture and sale of nursing care products, medical surgical products, original equipment manufacturer products (OEM), incontinence products in Europe and other medical supply products; and

• Retail Products, which includes the development, manufacture and marketing of infant care products, incontinence products in the United States, feminine hygiene products and other retail products.


Our customers include hospitals, surgi-centers, imaging centers, alternate site facilities, drug manufacturers and major retailers throughout the world. We often negotiate with GPOs and integrated delivery networks (IDNs), which enter into supply contracts for the benefit of their member facilities. We serve customers in over 130 countries and we maintain a strong local presence in each of the geographic areas in which we operate.

Raw Materials

We use a wide variety of resin, pulp, plastics, textiles and electrical components for production of our products. We purchase these materials from external suppliers, some of which are single-source suppliers. We also purchase certain other raw materials used in the bulk pharmaceutical business from non-U.S. governments and suppliers that meet U.S. State Department requirements. We purchase materials from selected suppliers based on quality assurance, cost effectiveness or constraints resulting from regulatory requirements and work closely with our suppliers to assure continuity of supply while maintaining high quality and reliability.


We generally compete in medical device, pharmaceutical and other healthcare product markets around the world. These global markets are characterized by continuous change resulting from technological innovations. Our market position depends on our ability to develop and commercialize products that meet clinician needs, while offering reliable product quality, cost-effectiveness and dependable service. Our competitors range from large manufacturers with multiple business lines, including Johnson & Johnson, Becton Dickinson and C.R. Bard, among others, to smaller manufacturers that focus on a limited selection of products.

Medical Devices. The medical devices market is highly fragmented and competitive. According to the International Trade Administration, there are approximately 8,000 companies in the United States operating in the medical devices market. There is no single company, however, that competes with us over the full breadth of products offered by our Medical Devices segment. Our competition includes both diversified healthcare companies, such as Johnson & Johnson, C.R. Bard and Becton Dickinson, and other companies that are more focused on specific fields, including Respironics and ConMed.

Pharmaceutical Products. Our major competitors of our active ingredients product line include Johnson & Johnson, Siegfried and Johnson Matthey, and major competitors of our dosage product line include Teva, Mylan and Watson. Although competition is steadily increasing and we expect new entrants into this market, we believe our ability to meet strict production and licensing requirements for controlled substances will enable us to compete effectively. Purchasing decisions in this segment of the industry are based on price and the ability to ensure a stable and sufficient supply of pharmaceuticals to customers. Our secure sources of raw opiate material, manufacturing capabilities, comprehensive generic pain management offering and established relationships with retail pharmacies enable us to compete effectively against larger generics manufacturers such as Teva and Watson. In addition, we believe that our experience with the U.S. Food and Drug Administration (“FDA”) and U.S Drug Enforcement Agency (“DEA”) provides us with the knowledge to successfully navigate a tightening regulatory environment.

Imaging Solutions. Our main competitors include GE Healthcare for contrast and nuclear medicine products, Schering AG and its U.S. affiliate Berlex, as well as Bracco for contrast agents, and Bristol-Myers Squibb for nuclear medicine cardiology agents. Cardinal Health is our main competitor for our radiopharmacy network. Unlike most of our competition, we offer a full line of contrast agents, contrast delivery systems and radiopharmaceuticals. Our broad product portfolio allows us to be a complete source for all imaging agent needs.

Medical Supplies. The markets in which our Medical Supplies segment participates are characterized by strong pricing competition. While customers may choose our products based upon our reputation for quality, we face strong competition from low-cost suppliers. Our Medical Supplies segment competes against branded products, including ones sold by 3M, ConMed and First Quality, as well as private-label products provided by low-cost suppliers, such as Cardinal and Medline.

Retail Products. The market in which our Retail Products segment participates is highly competitive, as our private-label products compete directly with national brands. Our retail competitors include national branded manufacturers, including Kimberly-Clark, Procter & Gamble and Johnson & Johnson. We also compete with other private-label producers, such as Arquest and Associated Hygienic Products. We believe that our high-quality products, product innovation, packaging solutions and customer service provide us a competitive advantage. However, we expect continued and severe price pressure in this segment.



Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Est E Lauder Companies Inc

Confronting the challenges, the Est E Lauder Companies Inc amid the financial span ending December 31 2022

For the second quarter of 2022 Est E Lauder Companies Inc earnings per share dived by -63.3 % of $1.09 per share compare to $2.97 a year ago and profits fell by -19.26 % from $1.35 per share from the prior quarter.

Sales decreased substantially by -16.591 % to $4.62 billions from $5.54 billions in the corresponding quarter a year ago and sequentially Sales improved by 17.557 % from $3.93 billions.

Synaptics Incorporated

Serious Sales deterioration, at the company amid the second quarter of 2022 earnings season

For the financial interval closing December 24 2022 company income per share dived by -67.84 % of $0.55 per share compare to $1.71 a year ago and earnings per share dropped by -65.41 % from $1.59 per share from the prior financial reporting period.

Sales decreased substantially by -16.029 % to $353.10 millions from $420.50 millions in the comparable financial reporting period a year ago and sequentially Sales fell by -21.201 % from $448.10 millions.

Open Text Corp

Profits Rose by 200 % but Revenues took a dive at the OTEX over the October to December 31 2022 period

Open Text Corp published strong income improvement of 200 % to $0.96 per share, on fading Sales of -22.882 % to $810.92 millions in the Dec 31 2022 report, relative to the preceding year.

World Wrestling Entertainment Inc

EPS Drops at WWE over the October to December 31 2022 time-frame

company announced declining eps on increasing revenue in the financial period ending December 31 2022, where Sales rose by 4.849 % to $325.30 millions relative to $310.26 millions on a year-over-year basis, while earnings per share plummeted by -42.12 % to $0.42 per share, income per share was $0.72 in the financial period ending December 31 2021.

Rave Restaurant Group Inc

Reasonable behavior at Rave Restaurant Group Inc in the October to December 25 2022 time-frame

For the second quarter of 2022 Rave Restaurant Group Inc earnings per share remained unchanged of $0.02 per share compare to $0.02 a year before and EPS remained unchanged from $0.02 per share from the previous quarter.

Sales grew by 6.306 % to $2.87 millions from $2.70 millions in the corresponding quarter a year before and sequentially Sales decreased by -4.626 % from $3.01 millions.


's Segments
Medical Devices
 Segment     of total Revenue
Advanced Surgical
 Segment     of total Revenue
General Surgical
 Segment     of total Revenue
Total Surgical Solutions
 Segment     of total Revenue
Airway & Ventilation Products
 Segment     of total Revenue
Patient Monitoring
 Segment     of total Revenue
Nursing Care
 Segment     of total Revenue
Patient Care
 Segment     of total Revenue
Total Respiratory Patient Care
 Segment     of total Revenue
Peripheral Vascular
 Segment     of total Revenue
 Segment     of total Revenue
Total Vascular Therapies
 Segment     of total Revenue
Medical Supplies
 Segment     of total Revenue
• View Complete Report
  Company Estimates  
  Revenue Outlook
does not provide revenue guidance.

Earnings Outlook
Rave Restaurant Group Inc does not provide earnings estimates.

Geographic Revenue Dispersion
United States
Non U.S. Developed Markets
Emerging Markets


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

STBX's Profile

Stock Price

STBX's Financials

Business Description


Charts & Quotes

STBX's News


STBX's Competitors

Customers & Markets

Economic Indicators

STBX's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries




At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071